126 related articles for article (PubMed ID: 34927542)
1. Evaluating the effect of nipple stimulation during labour on labour progression in term pregnant women.
Mousavi S; Rouhollahi B; Zakariya NA; Bastani Alamdari P; Nikniaz L
J Obstet Gynaecol; 2022 Jul; 42(5):994-998. PubMed ID: 34927542
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Uterine and Nipple Stimulation on Induction With Oxytocin and the Labor Process.
Demirel G; Guler H
Worldviews Evid Based Nurs; 2015 Oct; 12(5):273-80. PubMed ID: 26444882
[TBL] [Abstract][Full Text] [Related]
3. Intrapartum nipple stimulation therapy for labor induction: a randomized controlled external pilot study of acceptability and feasibility.
Stark EL; Athens ZG; Son M
Am J Obstet Gynecol MFM; 2022 Mar; 4(2):100575. PubMed ID: 35042047
[TBL] [Abstract][Full Text] [Related]
4. CONDISOX- continued versus discontinued oxytocin stimulation of induced labour in a double-blind randomised controlled trial.
Boie S; Glavind J; Uldbjerg N; Bakker JJH; van der Post JAM; Steer PJ; Bor P
BMC Pregnancy Childbirth; 2019 Sep; 19(1):320. PubMed ID: 31477047
[TBL] [Abstract][Full Text] [Related]
5. Continued versus discontinued oxytocin stimulation in the active phase of labour (CONDISOX): double blind randomised controlled trial.
Boie S; Glavind J; Uldbjerg N; Steer PJ; Bor P;
BMJ; 2021 Apr; 373():n716. PubMed ID: 33853878
[TBL] [Abstract][Full Text] [Related]
6. Labour management and Obstetric outcomes among pregnant women admitted in latent phase compared to active phase of labour at Bugando Medical Centre in Tanzania.
Chuma C; Kihunrwa A; Matovelo D; Mahendeka M
BMC Pregnancy Childbirth; 2014 Feb; 14():68. PubMed ID: 24521301
[TBL] [Abstract][Full Text] [Related]
7. Efficacy comparison of titrated oral solution of misoprostol and intravenous oxytocin on labour induction in women with full-term pregnancy.
Kashanian M; Eshraghi N; Rahimi M; Sheikhansari N; Javanmanesh F
J Obstet Gynaecol; 2020 Jan; 40(1):20-24. PubMed ID: 31195867
[TBL] [Abstract][Full Text] [Related]
8. Acupuncture or acupressure for induction of labour.
Smith CA; Armour M; Dahlen HG
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002962. PubMed ID: 29036756
[TBL] [Abstract][Full Text] [Related]
9. Continuation versus discontinuation of oxytocin infusion during the active phase of labour: a randomised controlled trial.
Bor P; Ledertoug S; Boie S; Knoblauch NO; Stornes I
BJOG; 2016 Jan; 123(1):129-35. PubMed ID: 26309128
[TBL] [Abstract][Full Text] [Related]
10. Induction of labour in term premature rupture of membranes; oxytocin versus sublingual misoprostol; a randomised clinical trial.
Pourali L; Saghafi N; Eslami Hasan Abadi S; Tara F; Vatanchi AM; Motamedi E
J Obstet Gynaecol; 2018 Feb; 38(2):167-171. PubMed ID: 28784054
[TBL] [Abstract][Full Text] [Related]
11. EFFECTIVENESS AND SAFETY OF 2-HOURLY 20 MCG ORAL MISOPROSTOL SOLUTION COMPARED TO STANDARD INTRAVENOUS OXYTOCIN IN LABOUR INDUCTION DUE TO PRE-LABOUR RUPTURE OF MEMBRANES AT TERM: A RANDOMISED CLINICAL TRIAL AT KENYATTA NATIONAL HOSPITAL.
Mbaluka CM; Kamau K; Karanja JG; Mugo N
East Afr Med J; 2014 Sep; 91(9):303-10. PubMed ID: 26866082
[TBL] [Abstract][Full Text] [Related]
12. Methods of term labour induction for women with a previous caesarean section.
Jozwiak M; Dodd JM
Cochrane Database Syst Rev; 2013 Mar; (3):CD009792. PubMed ID: 23543582
[TBL] [Abstract][Full Text] [Related]
13. High-dose versus low-dose of oxytocin for labour augmentation: a randomised controlled trial.
Selin L; Wennerholm UB; Jonsson M; Dencker A; Wallin G; Wiberg-Itzel E; Almström E; Petzold M; Berg M
Women Birth; 2019 Aug; 32(4):356-363. PubMed ID: 30341003
[TBL] [Abstract][Full Text] [Related]
14. Oral Misoprostol alone versus oral misoprostol followed by oxytocin for labour induction in women with hypertension in pregnancy (MOLI): protocol for a randomised controlled trial.
Bracken H; Lightly K; Mundle S; Kerr R; Faragher B; Easterling T; Leigh S; Turner M; Alfirevic Z; Winikoff B; Weeks A
BMC Pregnancy Childbirth; 2021 Jul; 21(1):537. PubMed ID: 34325670
[TBL] [Abstract][Full Text] [Related]
15. A randomised controlled trial of early versus delayed oxytocin augmentation to treat primary dysfunctional labour in nulliparous women.
Hinshaw K; Simpson S; Cummings S; Hildreth A; Thornton J
BJOG; 2008 Sep; 115(10):1289-95; discussion 1295-6. PubMed ID: 18715415
[TBL] [Abstract][Full Text] [Related]
16. Misoprostol for induction of labour at term: a more effective agent than dinoprostone vaginal gel.
Danielian P; Porter B; Ferri N; Summers J; Templeton A
Br J Obstet Gynaecol; 1999 Aug; 106(8):793-7. PubMed ID: 10453828
[TBL] [Abstract][Full Text] [Related]
17. High-dose compared with low-dose oxytocin for induction of labour of nulliparous women at term.
Prichard N; Lindquist A; Hiscock R; Ruff S; Tong S; Brownfoot FC
J Matern Fetal Neonatal Med; 2019 Feb; 32(3):362-368. PubMed ID: 28889775
[TBL] [Abstract][Full Text] [Related]
18. Prelabour rupture of the membranes at term--no advantage of delaying induction for 24 hours.
Akyol D; Mungan T; Unsal A; Yüksel K
Aust N Z J Obstet Gynaecol; 1999 Aug; 39(3):291-5. PubMed ID: 10554936
[TBL] [Abstract][Full Text] [Related]
19. Continued versus discontinued oxytocin stimulation in the active phase of induced labour: Factors associated with unexpectedly high rates of conversion to open label oxytocin in the CONDISOX trial.
Steer PJ; Glavind J; Uldbjerg N; Bor P; Boie S
BJOG; 2023 May; 130(6):636-642. PubMed ID: 36651106
[TBL] [Abstract][Full Text] [Related]
20. Package of care for active management in labour for reducing caesarean section rates in low-risk women.
Brown HC; Paranjothy S; Dowswell T; Thomas J
Cochrane Database Syst Rev; 2013 Sep; (9):CD004907. PubMed ID: 24043476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
